Cargando…

Preadipocyte factor 1 induces pancreatic ductal cell differentiation into insulin-producing cells

The preadipocyte factor 1 (Pref-1) is involved in the proliferation and differentiation of various precursor cells. However, the intracellular signaling pathways that control these processes and the role of Pref-1 in the pancreas remain poorly understood. Here, we showed that Pref-1 induces insulin...

Descripción completa

Detalles Bibliográficos
Autores principales: Rhee, Marie, Lee, Seung-Hwan, Kim, Ji-Won, Ham, Dong-Sik, Park, Heon-Seok, Yang, Hae Kyung, Shin, Ju-Young, Cho, Jae-Hyoung, Kim, Young-Bum, Youn, Byung-Soo, Sul, Hei Sook, Yoon, Kun-Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4820710/
https://www.ncbi.nlm.nih.gov/pubmed/27044861
http://dx.doi.org/10.1038/srep23960
Descripción
Sumario:The preadipocyte factor 1 (Pref-1) is involved in the proliferation and differentiation of various precursor cells. However, the intracellular signaling pathways that control these processes and the role of Pref-1 in the pancreas remain poorly understood. Here, we showed that Pref-1 induces insulin synthesis and secretion via two independent pathways. The overexpression of Pref-1 activated MAPK signaling, which induced nucleocytoplasmic translocation of FOXO1 and PDX1 and led to the differentiation of human pancreatic ductal cells into β-like cells and an increase in insulin synthesis. Concurrently, Pref-1 activated Akt signaling and facilitated insulin secretion. A proteomics analysis identified the Rab43 GTPase-activating protein as a downstream target of Akt. A serial activation of both proteins induced various granular protein syntheses which led to enhanced glucose-stimulated insulin secretion. In a pancreatectomised diabetic animal model, exogenous Pref-1 improved glucose homeostasis by accelerating pancreatic ductal and β-cell regeneration after injury. These data establish a novel role for Pref-1, opening the possibility of applying this molecule to the treatment of diabetes.